Articles

High-Risk Medication Adherence in Home and Community Settings: Detecting Hidden Nonadherence Before It Becomes Harm
In home and community settings, nonadherence to high-risk medications is often hidden until a crisis occurs. This article explains how providers detect and manage nonadherence using workflow, verification, and escalation systems that reduce avoidable ED use and deterioration. Read more...
High-Risk Medication Reconciliation When Multiple Prescribers Are Involved: Building a Single Source of Truth
High-risk medication harm often comes from mismatched lists across hospital, specialists, primary care, and post-acute teams. This article explains how providers build a single source of truth for reconciliation, ownership, and change control when multiple prescribers are involved. Read more...
High-Risk Medication Deprescribing After Discharge: Preventing Harm From Indefinite Continuation
Many high-risk medications initiated in acute care persist indefinitely after discharge without review. This article explains how post-acute providers design deprescribing controls that reduce harm while meeting regulatory and payer expectations. Read more...
High-Risk Medication Monitoring After Discharge: Designing Escalation That Survives Nights, Weekends, and Coverage Gaps
Post-discharge medication harm often occurs because monitoring responsibility collapses outside office hours. This article explains how post-acute providers design high-risk medication monitoring and escalation systems that remain reliable across nights, weekends, and fragmented coverage. Read more...
High-Risk Medication Registry and Weekly Review: Building Cross-Setting Monitoring Ownership After Discharge
High-risk medications fail when no one owns the monitoring calendar across settings. This article sets out a practical model for a shared high-risk medication registry, weekly multidisciplinary review, and escalation pathways that reduce adverse drug events and demonstrate control to Medicare Advantage plans and state oversight. Read more...
Deprescribing After Post-Acute Transitions: Operational Controls That Reduce Falls, Delirium, and Readmissions
Post-acute polypharmacy often persists by default, increasing falls, delirium, and avoidable ED use. This article explains how SNF, home health, and HCBS partners operationalize deprescribing with clear decision rights, monitoring backstops, and an audit trail that satisfies payers and surveyors. Read more...
Medication Reconciliation After Discharge: Preventing High-Risk Discrepancies Across SNF, Home Health, and HCBS
Medication reconciliation failures are a leading driver of post-discharge harm, particularly for high-risk drugs. This article explains how providers design reconciliation processes that detect discrepancies early, assign correction authority, and prevent silent medication errors across post-acute and community settings. Read more...
High-Risk Medication Management at Post-Acute Interfaces: Designing Controls That Prevent Early Harm
High-risk medication harm after discharge happens fastest at care interfaces, not in isolation. This article explains how SNFs, home health agencies, and HCBS-linked teams design practical controls that prevent early medication harm through ownership clarity, monitoring reliability, and escalation pathways that function across settings. Read more...
Deprescribing After Discharge: Governance That Prevents Polypharmacy Drift Across SNF, Home Health, and HCBS
Polypharmacy rarely improves after discharge unless someone is accountable for stopping medications, not just starting them. This article explains how providers run deprescribing governance across SNF, home health, and HCBS, with structured reviews, cross-setting decision authority, and documentation that meets payer and survey expectations. Read more...
High-Risk Medication Registries After Discharge: Building Monitoring Calendars Across SNF, Home Health, and HCBS
High-risk medication harm after discharge is often a tracking failure, not a prescribing failure. This article shows how providers build shared high-risk medication registries, monitoring calendars, and escalation workflows across SNF, home health, and HCBS so labs, symptoms, and stop-dates are owned, completed, and auditable. Read more...
Anticoagulant Safety After Discharge: Managing Bleeding Risk Across SNF, Home Health, and HCBS
Anticoagulants save lives but create significant post-discharge risk when monitoring and escalation are weak. This article explores how post-acute providers operationalize anticoagulant safety through laboratory tracking, symptom surveillance, and governance that prevents silent harm and litigation exposure. Read more...
Insulin and Hypoglycemic Safety in Post-Acute Care: Preventing Silent Deterioration Between Visits
Insulin and hypoglycemic medications are a leading cause of avoidable harm after discharge, particularly when monitoring intensity drops. This article explains how post-acute and HCBS providers design day-to-day controls that prevent hypoglycemia, delayed escalation, and emergency utilization across SNF and home health settings. Read more...